These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2280672)

  • 1. Comparison of the effect of six compactin-related compounds on cholesterol synthesis in five human cell types.
    Sviridov DD; Endo A; Pavlov MYu ; Repin VS; Smirnov VN
    Lipids; 1990 Nov; 25(11):685-90. PubMed ID: 2280672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time response of cholesterol synthesis inhibition by compactin-related compounds. In vitro quantitation of the "escape phenomenon".
    Sviridov DD; Endo A; Pavlov MY; Repin VS
    Lipids; 1993 Jun; 28(6):569-71. PubMed ID: 8355584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical aspect of HMG CoA reductase inhibitors.
    Endo A; Hasumi K
    Adv Enzyme Regul; 1989; 28():53-64. PubMed ID: 2696346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
    Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
    Fears R; Richards DH; Ferres H
    Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.
    Boogaard A; Griffioen M; Cohen LH
    Biochem J; 1987 Jan; 241(2):345-51. PubMed ID: 3036060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
    Endo A
    J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
    Serajuddin AT; Ranadive SA; Mahoney EM
    J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of simvastatin (MK-733) on the regulation of cholesterol synthesis in Hep G2 cells.
    Nagata Y; Hidaka Y; Ishida F; Kamei T
    Biochem Pharmacol; 1990 Aug; 40(4):843-50. PubMed ID: 2167097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry, biochemistry, and pharmacology of HMG-CoA reductase inhibitors.
    Endo A
    Klin Wochenschr; 1988 May; 66(10):421-7. PubMed ID: 3294493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
    Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ
    Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hydroxymethylglutaryl coenzyme A reductase activity induces a paradoxical increase in DNA synthesis in myeloid leukemia cells.
    Hohl RJ; Larson RA; Mannickarottu V; Yachnin S
    Blood; 1991 Mar; 77(5):1064-70. PubMed ID: 1995091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compactin-a review.
    Chakravarti R; Sahai V
    Appl Microbiol Biotechnol; 2004 Jun; 64(5):618-24. PubMed ID: 15034683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia.
    Haba T; Mabuchi H; Yoshimura A; Watanabe A; Wakasugi T; Tatami R; Ueda K; Ueda R; Kametani T; Koizumi J; Miyamoto S; Takeda R; Takeshita H
    J Clin Invest; 1981 May; 67(5):1532-40. PubMed ID: 7229037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydromonacolin L and monacolin X, new metabolites which inhibit cholesterol biosynthesis.
    Endo A; Hasumi K; Nakamura T; Kunishima M; Masuda M
    J Antibiot (Tokyo); 1985 Mar; 38(3):321-7. PubMed ID: 3839224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor.
    Fairbanks KP; Witte LD; Goodman DS
    J Biol Chem; 1984 Feb; 259(3):1546-51. PubMed ID: 6693424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of plasma cholesterol by compactin and mevinolin.
    Nutr Rev; 1985 Sep; 43(9):266-8. PubMed ID: 3903562
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia.
    Betteridge DJ; Krone W; Reckless JP; Galton DJ
    Lancet; 1978 Dec 23-30; 2(8104-5):1342-3. PubMed ID: 82843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.